Variant report
Variant | esv3369439 |
---|---|
Chromosome Location | chr5:12643452-12646950 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs78261380 | chr5:12643518-12643519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs58520287 | chr5:12643532-12643533 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs371960367 | chr5:12643556-12643557 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs369706686 | chr5:12643571-12643572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs140068368 | chr5:12643593-12643594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs187521615 | chr5:12643731-12643732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs545726195 | chr5:12643778-12643779 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs543876602 | chr5:12643820-12643821 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs192487956 | chr5:12643859-12643860 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs4702890 | chr5:12643875-12643876 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs183825264 | chr5:12643891-12643892 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs188892012 | chr5:12643921-12643922 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs529057133 | chr5:12643928-12643929 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs547540079 | chr5:12643952-12643953 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs559298893 | chr5:12643955-12643956 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs533212055 | chr5:12643989-12643990 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs551264671 | chr5:12643990-12643991 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs146962319 | chr5:12643993-12643994 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs148320471 | chr5:12644003-12644004 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs371649382 | chr5:12644032-12644033 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs532934516 | chr5:12644062-12644063 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs548649138 | chr5:12644082-12644083 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs538733954 | chr5:12644161-12644162 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs567380988 | chr5:12644163-12644164 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs12518818 | chr5:12644215-12644216 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs137974806 | chr5:12644225-12644226 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs552718202 | chr5:12644283-12644284 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs192906556 | chr5:12644288-12644289 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs539338489 | chr5:12644300-12644301 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs182932809 | chr5:12644312-12644313 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs575694076 | chr5:12644325-12644326 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs72733268 | chr5:12644349-12644350 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs142545184 | chr5:12644426-12644427 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs547287705 | chr5:12644440-12644441 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs573254386 | chr5:12644486-12644487 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs114283238 | chr5:12644559-12644560 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs568774621 | chr5:12644566-12644567 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs559450950 | chr5:12644573-12644574 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs78462633 | chr5:12644599-12644600 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs187305674 | chr5:12644603-12644604 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs563275565 | chr5:12644611-12644612 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs370257722 | chr5:12644633-12644634 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs146664714 | chr5:12644719-12644720 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs73043716 | chr5:12644783-12644784 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs373592360 | chr5:12644829-12644830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs11748674 | chr5:12644859-12644860 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
47 | rs12055239 | chr5:12644961-12644962 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs34936344 | chr5:12644972-12644973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs72260661 | chr5:12644973-12644974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs539576574 | chr5:12645072-12645073 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cervical squamous cell carcinoma | 21590768 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cri-du chat syndrome | 16773131 | CNVD |
Cryptorchidism | 21048976 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Cervical cancer | 16585170 | CNVD |
Mental retardation | 16773131 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Cri-du chat syndrome | 22470819 | CNVD |
sporadic birth defects | 19047251 | CNVD |
Non-small cell lung cancer | 17643093 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Schizophrenia | 18940311 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Mental retardation | 17847001 | CNVD |
Neurocytoma | 17123091 | CNVD |
Mental retardation | 19546859 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Schizophrenia | 21346763 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:12636600-12643800 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
2 | chr5:12636600-12659200 | Weak transcription | K562 | blood |
3 | chr5:12636800-12655600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
4 | chr5:12643800-12644600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr5:12644200-12644600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr5:12644200-12644800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr5:12644400-12644600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr5:12644600-12657000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr5:12644600-12658400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
10 | chr5:12644800-12654800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |